Replies to post #208314 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

https://ih.advfn.com/stock-market/NASDAQ/anavex-life-sciences-AVXL/stock-news/80659234/anavex-life-sciences-announces-initiation-of-the-e

biotechnician

Missling never moves ahead if negative occurences happen.

This is an excellent and timely process observation. There is absolutely no reason the new process being put forward cannot be documented and a key word (established=define/document/do) world wide. The FDA for example is very good at that.

Getting results over time is what this is all about. He now plans to implement this new program/trials method WW. He/we have BP surrounded and they know it. The smart ones will stop resisting soon. W/S thieves will do what they do.

We do have one major strength and he is using it, NO ONE HAS EVER TREATED CNS DISEASES EFFECTIVLY. IMO, it will only take one validation of the AVXL CNS cellular Homeostasis thesis to start the avalanche.

[attilathehunt]

“I agree. I am in the camp that they must have scene something to go into the pediatric market for Rhett.”

Or perhaps, they didn’t see anything special and now moving upstream to ascertain if A2-73 works at an earlier onset. One never knows what TGD is thinking except for maintaining a 2 year cash position. I suspect we will hear of a larger dilution before end of year since no top line data will be available. I expect the dilution PR to follow full enrollment PR. Hang on for the ride.